Literature DB >> 18391187

Galpha(i2) inhibition of adenylate cyclase regulates presynaptic activity and unmasks cGMP-dependent long-term depression at Schaffer collateral-CA1 hippocampal synapses.

Christopher P Bailey1, Russell E Nicholls, Xiao-lei Zhang, Zhen-yu Zhou, Wolfgang Müller, Eric R Kandel, Patric K Stanton.   

Abstract

Cyclic AMP signaling plays a central role in regulating activity at a number of synapses in the brain. We showed previously that pairing activation of receptors that inhibit adenylate cyclase (AC) and reduce the concentration of cyclic AMP, with elevation of the concentration of cyclic GMP is sufficient to elicit a presynaptically expressed form of LTD at Schaffer collateral-CA1 synapses in the hippocampus. To directly test the role of AC inhibition and G-protein signaling in LTD at these synapses, we utilized transgenic mice that express a mutant, constitutively active inhibitory G protein, Galpha(i2), in principal neurons of the forebrain. Transgene expression of Galpha(i2) markedly enhanced LTD and impaired late-phase LTP at Schaffer collateral synapses, with no associated differences in input/output relations, paired-pulse facilitation, or NMDA receptor-gated conductances. When paired with application of a type V phosphodiesterase inhibitor to elevate the concentration of intracellular cyclic GMP, constitutively active Galpha(i2) expression converted the transient depression normally caused by this treatment to an LTD that persisted after the drug was washed out. Moreover, this effect could be mimicked in control slices by pairing type V phosphodiesterase inhibitor application with application of a PKA inhibitor. Electrophysiological recordings of spontaneous excitatory postsynaptic currents and two-photon visualization of vesicular release using FM1-43 revealed that constitutively active Galpha(i2) tonically reduced basal release probability from the rapidly recycling vesicle pool of Schaffer collateral terminals. Our findings support the hypothesis that inhibitory G-protein signaling acts presynaptically to regulate release, and, when paired with elevations in the concentration of cyclic GMP, converts a transient cyclic GMP-induced depression into a long-lasting decrease in release.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18391187      PMCID: PMC2327268          DOI: 10.1101/lm.810208

Source DB:  PubMed          Journal:  Learn Mem        ISSN: 1072-0502            Impact factor:   2.460


  56 in total

1.  Chemically induced, activity-independent LTD elicited by simultaneous activation of PKG and inhibition of PKA.

Authors:  L Santschi; M Reyes-Harde; P K Stanton
Journal:  J Neurophysiol       Date:  1999-09       Impact factor: 2.714

2.  Inhibition of the cAMP pathway decreases early long-term potentiation at CA1 hippocampal synapses.

Authors:  N A Otmakhova; N Otmakhov; L H Mortenson; J E Lisman
Journal:  J Neurosci       Date:  2000-06-15       Impact factor: 6.167

Review 3.  Regulation of adenylyl cyclase in the central nervous system.

Authors:  Y Chern
Journal:  Cell Signal       Date:  2000-04       Impact factor: 4.315

4.  Imaging LTP of presynaptic release of FM1-43 from the rapidly recycling vesicle pool of Schaffer collateral-CA1 synapses in rat hippocampal slices.

Authors:  Patric K Stanton; Jochen Winterer; Xiao-Lei Zhang; Wolfgang Müller
Journal:  Eur J Neurosci       Date:  2005-11       Impact factor: 3.386

5.  Genetic evidence for a protein-kinase-A-mediated presynaptic component in NMDA-receptor-dependent forms of long-term synaptic potentiation.

Authors:  Yan-You Huang; Stanislav S Zakharenko; Susanne Schoch; Pascal S Kaeser; Roger Janz; Thomas C Südhof; Steven A Siegelbaum; Eric R Kandel
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-20       Impact factor: 11.205

6.  Gamma-aminobutyric acid type A receptors modulate cAMP-mediated long-term potentiation and long-term depression at monosynaptic CA3-CA1 synapses.

Authors:  T P Yu; S McKinney; H A Lester; N Davidson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

7.  FM1-43 imaging reveals cGMP-dependent long-term depression of presynaptic transmitter release.

Authors:  P K Stanton; U Heinemann; W Muller
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

8.  A high-efficiency protein transduction system demonstrating the role of PKA in long-lasting long-term potentiation.

Authors:  M Matsushita; K Tomizawa; A Moriwaki; S T Li; H Terada; H Matsui
Journal:  J Neurosci       Date:  2001-08-15       Impact factor: 6.167

9.  Induction of hippocampal LTD requires nitric-oxide-stimulated PKG activity and Ca2+ release from cyclic ADP-ribose-sensitive stores.

Authors:  M Reyes-Harde; B V Potter; A Galione; P K Stanton
Journal:  J Neurophysiol       Date:  1999-09       Impact factor: 2.714

10.  Some forms of cAMP-mediated long-lasting potentiation are associated with release of BDNF and nuclear translocation of phospho-MAP kinase.

Authors:  S L Patterson; C Pittenger; A Morozov; K C Martin; H Scanlin; C Drake; E R Kandel
Journal:  Neuron       Date:  2001-10-11       Impact factor: 17.173

View more
  9 in total

Review 1.  Role of presynaptic metabotropic glutamate receptors in the induction of long-term synaptic plasticity of vesicular release.

Authors:  Chirag Upreti; Xiao-Lei Zhang; Simon Alford; Patric K Stanton
Journal:  Neuropharmacology       Date:  2012-05-22       Impact factor: 5.250

2.  PDE-4 inhibition rescues aberrant synaptic plasticity in Drosophila and mouse models of fragile X syndrome.

Authors:  Catherine H Choi; Brian P Schoenfeld; Eliana D Weisz; Aaron J Bell; Daniel B Chambers; Joseph Hinchey; Richard J Choi; Paul Hinchey; Maria Kollaros; Michael J Gertner; Neal J Ferrick; Allison M Terlizzi; Nicole Yohn; Eric Koenigsberg; David A Liebelt; R Suzanne Zukin; Newton H Woo; Michael R Tranfaglia; Natalia Louneva; Steven E Arnold; Steven J Siegel; Francois V Bolduc; Thomas V McDonald; Thomas A Jongens; Sean M J McBride
Journal:  J Neurosci       Date:  2015-01-07       Impact factor: 6.167

3.  Altered neurotransmitter release, vesicle recycling and presynaptic structure in the pilocarpine model of temporal lobe epilepsy.

Authors:  Chirag Upreti; Rafael Otero; Carlos Partida; Frank Skinner; Ravi Thakker; Luis F Pacheco; Zhen-yu Zhou; Giorgi Maglakelidze; Jana Velíšková; Libor Velíšek; Dwight Romanovicz; Theresa Jones; Patric K Stanton; Emilio R Garrido-Sanabria
Journal:  Brain       Date:  2012-02-16       Impact factor: 13.501

Review 4.  Gβγ SNARE Interactions and Their Behavioral Effects.

Authors:  Simon Alford; Heidi Hamm; Shelagh Rodriguez; Zack Zurawski
Journal:  Neurochem Res       Date:  2018-05-11       Impact factor: 3.996

5.  Persistent modifications of hippocampal synaptic function during remote spatial memory.

Authors:  Alice Pavlowsky; Emma Wallace; André A Fenton; Juan Marcos Alarcon
Journal:  Neurobiol Learn Mem       Date:  2016-08-26       Impact factor: 2.877

6.  Gβγ and the C terminus of SNAP-25 are necessary for long-term depression of transmitter release.

Authors:  Xiao-lei Zhang; Chirag Upreti; Patric K Stanton
Journal:  PLoS One       Date:  2011-05-25       Impact factor: 3.240

7.  Promoter-Specific Effects of DREADD Modulation on Hippocampal Synaptic Plasticity and Memory Formation.

Authors:  Alberto J López; Enikö Kramár; Dina P Matheos; André O White; Janine Kwapis; Annie Vogel-Ciernia; Keith Sakata; Monica Espinoza; Marcelo A Wood
Journal:  J Neurosci       Date:  2016-03-23       Impact factor: 6.167

Review 8.  Synaptic Plasticity, Metaplasticity and Depression.

Authors:  Linnea R Vose; Patric K Stanton
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

9.  Loss of retinoid X receptor gamma subunit impairs group 1 mGluR mediated electrophysiological responses and group 1 mGluR dependent behaviors.

Authors:  Chirag Upreti; Caitlin M Woodruff; Xiao-Lei Zhang; Michael J Yim; Zhen-Yu Zhou; Andrew M Pagano; Dina S Rehanian; Deqi Yin; Eric R Kandel; Patric K Stanton; Russell E Nicholls
Journal:  Sci Rep       Date:  2021-03-10       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.